These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11854385)

  • 1. COX-2 inhibitors: cancer trials test new uses for pain drug.
    Michalowski J
    J Natl Cancer Inst; 2002 Feb; 94(4):248-9. PubMed ID: 11854385
    [No Abstract]   [Full Text] [Related]  

  • 2. COX-2 inhibitors in oncology.
    Haller DG
    Semin Oncol; 2003 Aug; 30(4 Suppl 12):2-8. PubMed ID: 14508721
    [No Abstract]   [Full Text] [Related]  

  • 3. [[Last news from ASCO 2000 in the topic of colorectal cancer] ].
    Sobrero A
    Tumori; 2000; 86(3):A1-2. PubMed ID: 10939611
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
    Bresalier RS
    Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
    [No Abstract]   [Full Text] [Related]  

  • 5. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K; Akay MT; Abbasoglu O; Ercan A
    Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arthritis drug approved for polyp prevention blazes trail for other prevention trials.
    Smigel K
    J Natl Cancer Inst; 2000 Feb; 92(4):297-9. PubMed ID: 10675374
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
    Keller JJ; Giardiello FM
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis.
    Bresalier RS
    Gastroenterology; 2000 Dec; 119(6):1797-8. PubMed ID: 11113106
    [No Abstract]   [Full Text] [Related]  

  • 11. COX-2 inhibitors and breast cancer.
    Singh Ranger G; Mokbel K
    ANZ J Surg; 2003 Aug; 73(8):565-6. PubMed ID: 12887516
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.
    Patrono C; Patrignani P; García Rodríguez LA
    J Clin Invest; 2001 Jul; 108(1):7-13. PubMed ID: 11435450
    [No Abstract]   [Full Text] [Related]  

  • 13. COX-2-selective inhibitors: clinical relevance in surgical and acute pain.
    Rowbotham DJ
    Eur J Anaesthesiol Suppl; 2002; 25():11-20. PubMed ID: 12449673
    [No Abstract]   [Full Text] [Related]  

  • 14. Celecoxib with chemotherapy in colorectal cancer.
    Blanke CD
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and arthritis share underlying processes.
    Ziegler J
    J Natl Cancer Inst; 1998 Jun; 90(11):802-3. PubMed ID: 9625164
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
    Masferrer JL; Leahy KM; Koki AT; Zweifel BS; Settle SL; Woerner BM; Edwards DA; Flickinger AG; Moore RJ; Seibert K
    Cancer Res; 2000 Mar; 60(5):1306-11. PubMed ID: 10728691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 inhibitors for colorectal cancer.
    Elder DJ; Paraskeva C
    Nat Med; 1998 Apr; 4(4):392-3. PubMed ID: 9546780
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of COX-2 inhibition in breast cancer treatment and prevention.
    Arun B; Goss P
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):22-9. PubMed ID: 15179621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective COX-2 inhibitors as chemopreventive and therapeutic agents.
    Grossman HB
    Drugs Today (Barc); 2003 Mar; 39(3):203-12. PubMed ID: 12730704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.